Literature DB >> 15334234

[Screening of occult spinal dysraphism by ultrasonography].

José Gilberto de Brito Henriques1, Geraldo Pianetti Filho, Petrônio Rabelo Costa, Karina Santos Wandeck Henriques, Francisco Otaviano Lima Perpétuo.   

Abstract

Ultrasonography for diagnosis of spinal cord diseases has been used since the eighties. There are different fields for its use: traumatic spine lesions, intra-operative use in trauma and spine tumors surgery, pre-operative and follow up study for spinal dysraphism, occult spinal dysraphism of the newborn. Patients with suspected occult spinal dysraphism are the most important indication for the method. Ultrasonography was performed in 292 patients of Hospital das Clínicas, Universidade Federal de Minas Gerais. Lesions such as conus medullaris lipomas, low level of conus medullaris, filum terminale tethering, cauda equina cysts and dermal sinuses can be well demonstrated. There is no difficulty in interpreting the image. The exam does not need sedation; it is safe, fast and cheap. Ideally it should be performed by the neurosurgeon as it may provide many information during the examination. The ultrasonography does not replace magnetic resonance imaging but it is an excellent method for screening.

Entities:  

Mesh:

Year:  2004        PMID: 15334234     DOI: 10.1590/s0004-282x2004000400025

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Diagnostic value of ultrasonography in spinal abnormalities among children with neurogenic bladder.

Authors:  Seyed Ali Alamdaran; Najmeh Mohammadpanah; Samira Zabihian; Mohammad Esmaeeli; Fatemeh Ghane; Ali Feyzi
Journal:  Electron Physician       Date:  2017-06-25

2.  Occult spinal dysraphism in the presence of rare cutaneous stigma in a neonate: importance of ultrasound and magnetic resonance imaging.

Authors:  Claudio Rodrigues Pires; Jane Marília Matos de Medeiros; Edward Araujo Júnior; Adriano Czapkowski; Sebastião Marques Zanforlin Filho
Journal:  Case Rep Med       Date:  2013-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.